Pages that link to "Q51552168"
Jump to navigation
Jump to search
The following pages link to Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance (Q51552168):
Displaying 43 items.
- Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony (Q24548698) (← links)
- The role of glucosamine-induced ER stress in diabetic atherogenesis (Q26830592) (← links)
- The hexosamine signaling pathway: deciphering the "O-GlcNAc code" (Q28284365) (← links)
- The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine (Q33625053) (← links)
- N-glycan remodeling on glucagon receptor is an effector of nutrient sensing by the hexosamine biosynthesis pathway (Q33718411) (← links)
- Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia (Q34075585) (← links)
- Comparative Effects of Fructose and Glucose on Lipogenic Gene Expression and Intermediary Metabolism in HepG2 Liver Cells (Q34077667) (← links)
- CREB and the CRTC co-activators: sensors for hormonal and metabolic signals (Q34166530) (← links)
- AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome (Q34310675) (← links)
- Increased hexosamine pathway flux and high fat feeding are not additive in inducing insulin resistance: evidence for a shared pathway (Q34538415) (← links)
- Hexosamines as mediators of nutrient sensing and regulation in diabetes. (Q34548619) (← links)
- Glucosamine-6-phosphate synthase--the multi-facets enzyme. (Q34666978) (← links)
- Identification of a biochemical link between energy intake and energy expenditure (Q34792500) (← links)
- The impact of blood on liver metabolite profiling - a combined metabolomic and proteomic approach (Q34915983) (← links)
- Intracellular glycosylation and development (Q34989577) (← links)
- Pleiotropic and age-dependent effects of decreased protein modification by O-linked N-acetylglucosamine on pancreatic β-cell function and vascularization. (Q35111129) (← links)
- Modulation of insulin action. (Q35628619) (← links)
- Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways (Q35955540) (← links)
- GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity (Q36140009) (← links)
- Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2 (Q36263001) (← links)
- Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3. (Q36538348) (← links)
- Nutrient shortage triggers the hexosamine biosynthetic pathway via the GCN2-ATF4 signalling pathway. (Q36964927) (← links)
- Proposed regulation of gene expression by glucose in rodent heart. (Q37380564) (← links)
- Differential hexosamine biosynthetic pathway gene expression with type 2 diabetes. (Q37434092) (← links)
- A Genetic Model to Study Increased Hexosamine Biosynthetic Flux. (Q38402162) (← links)
- New molecular insights in diabetic nephropathy (Q38694219) (← links)
- O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability (Q42076002) (← links)
- Insulin resistance of glycogen synthase mediated by o-linked N-acetylglucosamine. (Q42435341) (← links)
- Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity. (Q42466673) (← links)
- Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes (Q43819493) (← links)
- Integrated effects of multiple modulators on human liver glycogen phosphorylase a. (Q44030218) (← links)
- Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid (Q45197596) (← links)
- High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. (Q45232465) (← links)
- Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway. (Q46761365) (← links)
- Calcium-dependent O-GlcNAc signaling drives liver autophagy in adaptation to starvation (Q47807292) (← links)
- Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model (Q48018603) (← links)
- Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach (Q57577431) (← links)
- C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast-inducing chemokine CXCL10 (Q60628150) (← links)
- One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice (Q90179733) (← links)
- Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants (Q91795538) (← links)
- First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in ex vivo mouse heart (Q92502878) (← links)
- Metabolic and Epigenetic Action Mechanisms of Antidiabetic Medicinal Plants (Q92701392) (← links)
- GFPT2 promotes metastasis and forms a positive feedback loop with p65 in colorectal cancer (Q99241365) (← links)